Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like Abiomed Fourth Quarter Fiscal 2017 Earnings And Conference Call Notification April 12, 2017 Ablynx Banks $200M IPO in Nasdaq Debut October 24, 2017 Exactech Expands Presence In Japan With Newly Approved Shoulder, Knee And Hip Replacement Systems June 21, 2017
Exactech Expands Presence In Japan With Newly Approved Shoulder, Knee And Hip Replacement Systems June 21, 2017
